Accessibility Tools

A local pharmacist says Health Canada’s approval of a third vaccine is great news for rural communities like Dauphin.

Barret Procyshyn with the Dauphin Clinic Pharmacy says that's because the AstraZeneca vaccine doesn’t require ultra-cold storage — like the Pfizer and Moderna vaccines.

“We’re very excited because [AstraZeneca] is a fridge-stable vaccine, so that’s going to allow pharmacies and medical clinics across the province to vaccinate Manitobans, especially in rural and remote areas. This is perfect for the community setting; it’s great news for Dauphin.”

AstraZeneca’s vaccine was given the go-ahead for national use on Friday, after being under review since October.

Canada has secured 20 million doses of the vaccine, which has proven to be 62% effective at preventing infection, and in phase three trials showed 100% efficacy in preventing severe outcomes, such as hospitalization.

Procyshyn adds that it’s unclear when and how many vaccine doses will arrive in Manitoba, but appointments will be available as soon as possible.

Canada is slated to recieve 20 million doses of AstraZeneca between April and September, which is is enough to fully innoculate 10-million people.

Earlier this week, Manitoba officials opened up vaccine appointments to the general public starting with those 95 and older, and First Nations people 75 and older.